Image-Guided Radiation Therapy Market: Opportunities, Strategies, Size, Share, and Analysis 2024-2033

The Image-Guided Radiation Therapy Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Image-Guided Radiation Therapy Market:
https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report

According to The Business Research Company’s Image-Guided Radiation Therapy Global Market Report 2024, The image-guided radiation therapy market size has grown strongly in recent years. It will grow from $1.78 billion in 2023 to $1.89 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to growing industrialization, quality assurance requirements, regulatory compliance, expanding infrastructure projects, globalization of supply chains..

The image-guided radiation therapy market size is expected to see steady growth in the next few years. It will grow to $2.3 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to continued infrastructure development, evolving regulatory landscape, renewable energy expansion, increased focus on sustainable practices, rise in aerospace and automotive production.. Major trends in the forecast period include miniaturization and portability, advancements in x-ray tube technology, digital radiography adoption, integration of artificial intelligence (ai), customization for specific applications..

The increasing incidence of cancer is expected to propel the growth of the image-guided radiation therapy market going forward. Cancer refers to the uncontrolled proliferation and dissemination of abnormal cells within the body. Image-guided radiation therapy (IGRT) is used for cancer treatment due to its ability to provide precise and accurate radiation to cancer cells while minimizing damage to healthy tissue and reducing side effects. For instance, in January 2022, according to a report by the American Cancer Society, a US-based non-profit organization, the anticipated number of newly diagnosed cancer cases is around 2 million, which represents a significant increase of nearly over 10% compared to the 1.8 million new cases reported in 2021. Therefore, the increasing incidence of cancer is driving the growth of the image-guided radiation therapy market going forward.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13458&type=smp

The image-guided radiation therapy market covered in this report is segmented –

1) By Product Type: 4D Gating And 4D RT, Linear Accelerator (LINAC), PET And MRI Guided Radiation Therapy, Portal Imaging, CT Scanning

2) By Procedure: Intensity-Modulation Radiation Therapy, 3D Conformal Radiation Therapy, Stereotactic Therapy, Proton Beam Therapy, Particle Therapy

3) By Application: Lung Cancer, Prostate Cancer, Head And Neck Cancer, Gynecological Cancer, Gastrointestinal Cancer, Other Applications

4) By End User: Hospitals, Independent Radiotherapy Centers

Major companies operating in the image-guided radiation therapy market are focusing on technological advancements such as Cenos, which is an online adaptive therapy option for radiotherapy treatments. Cenos offers healthcare professionals the ability to promptly and effectively modify a radiation therapy treatment plan if needed while the patient is still undergoing treatment. For instance, in October 2023, Accuray Incorporated, a US-based manufacturer of radiation therapy systems, in partnership with Limbus AI, a Canada-based artificial intelligence company, launched the Cenos platform for its Radixact System. It is a state-of-the-art treatment delivery system that offers compromise-free capabilities to treat a wide range of cancer cases, including breast, prostate, lung, and head and neck cancers, as well as complex treatments such as total marrow irradiation. It has unique features, including a high-speed multileaf collimator, a fully integrated platform, and the Tomo C platform. Moreover, this therapy option provides healthcare providers with the option to carry out an online adjustment of their treatment plan to accommodate any changes that may arise between treatment sessions.

The image-guided radiation therapy market report table of contents includes: